Cancer-associated non-bacterial thrombotic endocarditis-Clinical series from a single institution.
Journal
American journal of hematology
ISSN: 1096-8652
Titre abrégé: Am J Hematol
Pays: United States
ID NLM: 7610369
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
received:
04
01
2024
accepted:
08
01
2024
pubmed:
13
2
2024
medline:
13
2
2024
entrez:
13
2
2024
Statut:
ppublish
Résumé
Premortem clinical presentation of cancer-associated non-bacterial thrombotic endocarditis (Ca-NBTE), therapy, and the clinal course is limited to case reports and small clinical series. An electronic search of Mayo Clinic records (03/31/2002-06/30/2022) with a subsequent manual review was performed to identify adult patients with echocardiographically detected NBTE and active malignancy, excluding those with infectious endocarditis or lupus anticoagulant/antiphospholipid antibodies. In this retrospective cohort study, we analyzed 115 Ca-NBTE patients (mean age 63.2 ± 9.7 years, 66.1% female) involving 71 (61.7%) mitral, 58 (50.4%) aortic, 8 (6.9%) tricuspid, and 1 (0.9%) pulmonary valve. The most common cancer was lung (n = 45 cases (39.1%), followed by pancreatic (n = 19, 16.5%), gynecological (17, 14.8%), gastrointestinal (n = 10, 8.7%), and 10 (8.7%) with hematologic malignancy; 6 patients had two active cancers. Embolic complications at presentation were frequent: 94 (81.7%) brain, 11 splenic, 10 renal, 6 coronary, and 4 to the extremities. Of 104 anticoagulated patients, 60 received low molecular weight heparin, 17 unfractionated heparin, 16 apixaban, 8 warfarin, and 3 rivaroxaban. There were 18 arterial thromboembolisms; the Kaplan-Meier estimates of the incidence at 2 years were consistent with a rate of 15.9% [95% Confidence Interval (CI) 9.9-23.3], including 14 strokes (12.4%, 95%CI, 7.1-19.2), and 8 other arterial emboli (10.5%, 95%CI, 4.7-18.9); there were 10 venous thromboembolisms (8.9%, 95%CI, 4.5-15.0). Fourteen major bleedings occurred (12.8%, 95%CI, 7.3-19.9) and 94 patients died during follow-up (77.9%, 95%CI, 71.1-85.8). Ca-NBTE predominantly affected women with lung adenocarcinoma or digestive tract cancers and manifested by stroke with high mortality and frequent embolic and bleeding complications during anticoagulation therapy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
596-605Subventions
Organisme : Mayo Clinic Health System, Gonda Vascular Center and Vascular Medicine Research
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Ziegler E. Ueber den Bau und die Entstehung der endocarditis chen Efflorescenzen. Ver Kong Inn Med. 1888;7:339-343.
Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J. 1987;113:773-784.
Macdonald RA, Robbins SL. The significance of nonbacterial thrombotic endocarditis: an autopsy and clinical study of 78 cases. Ann Intern Med. 1957;46:255-273.
Barron KD, Siqueira E, Hirano A. Cerebral embolism caused by nonbacterial thrombotic endocarditis. Neurology. 1960;10:391-397.
Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med. 1987;83(4):746-756.
Deppisch LM, Fayemi AO. Non-bacterial thrombotic endocarditis: clinicopathologic correlations. Am Heart J. 1976;92(6):723-729.
González Quintela A, Candela MJ, Vidal C, Román J, Aramburo P. Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46(1):1-9.
Gross L, Friedberg CK. Nonbacterial thrombotic endocarditis: classification and general description. Arch Intern Med. 1936;58:620-640.
Rohner RF, Prior JT, Sipple JH. Mucinous malignancies, venous thrombosis and terminal endocarditis with emboli: a syndrome. Cancer. 1966;1(9):1805-1812.
Estevez CM, Corya BC. Serial echocardiographic abnormalities in nonbacterial thrombotic endocarditis of the mitral valve. Chest. 1976;69:801-804.
Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol. 2006;97(6):894-898.
Patel MJ, Elzweig J. Non-bacterial thrombotic endocarditis: a rare presentation and literature review. BMJ Case Rep. 2020;13:e238585. doi:10.1136/bcr-2020-238585
Zmaili MA, Alzubi JM, Kocyigit D, et al. Contemporary 20-year Cleveland Clinic experience of nonbacterial thrombotic endocarditis: etiology, echocardiographic imaging, management, and outcomes. Am J Med. 2021;134(3):361-369.
Rahouma M, Khairallah S, Dabsha A, et al. Lung cancer as a leading cause among paraneoplastic non-bacterial thrombotic endocarditis: a meta-analysis of individual Patients' data. Cancers (Basel). 2023;15(6):1848.
Ketha SS, Pruthi RK, McBane RD, Wysokinski WE. Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation. J Thromb Thrombolysis. 2014;37(4):532-535.
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
Saric M, Armour AC, Arnaout MS, et al. Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism. J Am Soc Echocardiograph Off Publ Am\ Soc Echocardiograph. 2016;29:1-42.
Reisner SA, Brenner B, Haim N, Edoute Y, Markiewicz W. Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity. J Am Soc Echocardiograph Off Publ Am Soc Echocardiograph. 2000;13:876-881.
Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984;108:150-158.
Schulman S, Kearon C. Subcommittee on control of anticoagulation of the scientific and standardization Committee of the International Society on thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692-694.
Steiner I. Nonbacterial thrombotic versus infective endocarditis: a necropsy study of 320 cases. Cardiovasc Pathol. 1995;4:207-209.
Tsanaclis AM, Robert F. Cerebral embolism in nonbacterial thrombotic endocarditis associated with carcinoma. A clinico-pathological study. Acta Neurol Latinoam. 1976;22(1-4):86-103.
Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982;39(2):95-98.
Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw. 2006;4(6):631-638.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712-1723.
Reisner SA, Rinkevich D, Markiewicz W, Tatarsky I, Brenner B. Cardiac involvement in patients with myeloproliferative disorders. Am J Med. 1992;93(5):498-504.
Laco J, Steiner I, Havel E. Nonbacterial thrombotic endocarditis involving all four cardiac valves. Pathol Res Pract. 2008;204:757-761.
Kawada S, Kuriyama M, Kotani Y, Tsushima S, Tanabe A, Kioka Y. Nonbacterial thrombotic endocarditis involving all four cardiac valves. Asian Cardiovasc Thorac Ann. 2018;26(1):44-46.
Wysokinski WE, Houghton DE, Casanegra AI, et al. Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism. Am J Hematol. 2019;94(11):1185-1192.
Houghton DE, Vlazny DT, Casanegra AI, et al. Bleeding in patients with gastrointestinal cancer compared with nongastrointestinal cancer treated with Apixaban, rivaroxaban, or enoxaparin for acute venous thromboembolism. Mayo Clin Proc. 2021;96(11):2793-2805.
Dardiotis E, Aloizou AM, Markoula S, et al. Cancer-associated stroke: pathophysiology, detection and management (review). Int J Oncol. 2019;54(3):779-796.